Please assess the completion status of the following clinical trial:

Trial Title: 2-Week Study In People With Nonalcoholic Fatty Liver Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* controlled attenuation parameter greater than or equal to 260 dB/m via FibroScan~* liver fat greater than or equal to 6% via MRI~Exclusion Criteria:~* Chronic liver disease~* Type 2 diabetes requiring drug treatment~* Unable to undergo MRI~* History of heart attack or stroke

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- PF-06865571 100 mg (Type: EXPERIMENTAL): None
- PF-06865571 600 mg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).